XML 48 R32.htm IDEA: XBRL DOCUMENT v3.23.3

Business Combinations (Tables)

12 Months Ended

Sep. 30, 2023

Business Combinations [Abstract]

Schedule of Purchase Price Allocation

The purchase price was allocated to Bolder's tangible and identifiable intangible assets and liabilities based on their estimated fair values as of November 29, 2021, as set forth below.

Cash						$	1.9
Accounts receivable						1.3
Inventory						3.3
Other assets						3.0
Accounts payable and accrued expenses						(3.2)
Identifiable intangible assets:
			Developed technology			73.6
			Customer relationship			21.7
			Trade names			1.4
Deferred income taxes, net						(11.7)
Goodwill						68.8
Purchase Price						$	160.1

The total purchase price was allocated to Mobidiag's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of June 17, 2021, as set forth below.

Cash						$	7.0
Accounts receivable						4.2
Inventory						12.1
Other assets						29.6
Accounts payable and accrued expenses						(16.5)
Other liabilities						(12.2)
Identifiable intangible assets:
			Developed technology			285.0
			In-process research and development			74.0
			Customer relationships			20.9
			Trade names			20.0
Current debt						(66.1)
Deferred income taxes, net						(56.1)
Goodwill						427.7
Purchase Price						$	729.6

The total purchase price was allocated to Biotheranostics' tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.

Cash						$	9.6
Accounts receivable						6.6
Other assets						6.5
Accounts payable and accrued expenses						(8.2)
Other liabilities						(8.1)
Identifiable intangible assets:
			Developed technology			160.3
			Trade names			2.1
Deferred income taxes, net						(18.4)
Goodwill						80.9
Purchase Price						$	231.3

The total purchase price was allocated to Diagenode's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.

Cash						$	5.6
Accounts receivable						9.3
Inventory						9.0
Other assets						13.9
Accounts payable and accrued expenses						(16.7)
Other liabilities						(9.2)
Identifiable intangible assets:
			Developed technology			69.8
			Customer relationships			9.2
Deferred income taxes, net						(19.3)
Goodwill						83.5
Purchase Price						$	155.1

X

- References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Paragraph 1
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479907/805-20-50-1

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration